Evidence map›Paper›PMID 31024252›Full record

ArticleFrontiers in molecular neuroscience2019

Conditioned Medium of Human Menstrual Blood-Derived Endometrial Stem Cells Protects Against MPP

Han Li, Badrul Hisham Yahaya, Wai Hoe Ng, Narazah Mohd Yusoff, Juntang Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Neuroprotective effect of hyperoside in MPPMetabolic brain disease · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Han LiAdvanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Badrul Hisham YahayaAdvanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Wai Hoe NgAdvanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Narazah Mohd YusoffAdvanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Juntang LinStem Cell and Biotherapy Engineering Research Center of Henan, College of Life, Science and Technology, Xinxiang Medical University, Xinxiang, China.
Universiti Sains Malaysia · MYXinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) showed the potential to treat Parkinson's disease (PD). However, it is unknown whether the conditioned medium of human menstrual blood-derived endometrial stem cells (MenSCs-CM) has the function to alleviate syndromes of PD. In this study, human neuroblastoma SH-SY5Y cells were exposed to neurotoxicant 1-methyl-4-phenylpyridinium (MPP

Indexed as

conditioned mediuminflammationMPP+MSCsParkinson’s diseaseROSSH-SY5Y

Identifiers

PMID31024252
PMCPMC6460823
OpenAlexW2929880239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.